ArticleRSC advances2020

Targeting intracranial patient-derived glioblastoma (GBM) with a NIR-I fluorescent immunoconjugate for facilitating its image-guided resection.

Kenneth S Hettie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.